Diageo Shells Out $81M To Settle Aussie, NZ Thalidomide Suits
Diageo PLC agreed Monday to pay AU$89 million (US$81 million) to settle class action claims brought by Australians and New Zealanders with birth defects allegedly caused by the morning sickness drug...To view the full article, register now.
Already a subscriber? Click here to view full article